全文获取类型
收费全文 | 2579716篇 |
免费 | 181102篇 |
国内免费 | 5131篇 |
专业分类
耳鼻咽喉 | 35197篇 |
儿科学 | 84670篇 |
妇产科学 | 70220篇 |
基础医学 | 368307篇 |
口腔科学 | 74923篇 |
临床医学 | 231726篇 |
内科学 | 493381篇 |
皮肤病学 | 59370篇 |
神经病学 | 202420篇 |
特种医学 | 100012篇 |
外国民族医学 | 460篇 |
外科学 | 390825篇 |
综合类 | 54795篇 |
现状与发展 | 5篇 |
一般理论 | 795篇 |
预防医学 | 187524篇 |
眼科学 | 61429篇 |
药学 | 194696篇 |
13篇 | |
中国医学 | 6481篇 |
肿瘤学 | 148700篇 |
出版年
2021年 | 19573篇 |
2019年 | 20224篇 |
2018年 | 30011篇 |
2017年 | 23195篇 |
2016年 | 26241篇 |
2015年 | 29616篇 |
2014年 | 39889篇 |
2013年 | 58424篇 |
2012年 | 81079篇 |
2011年 | 85032篇 |
2010年 | 50316篇 |
2009年 | 46513篇 |
2008年 | 78862篇 |
2007年 | 84557篇 |
2006年 | 85047篇 |
2005年 | 81961篇 |
2004年 | 78725篇 |
2003年 | 75318篇 |
2002年 | 72605篇 |
2001年 | 131360篇 |
2000年 | 134298篇 |
1999年 | 111654篇 |
1998年 | 29517篇 |
1997年 | 25776篇 |
1996年 | 25598篇 |
1995年 | 24390篇 |
1994年 | 22284篇 |
1993年 | 20804篇 |
1992年 | 83556篇 |
1991年 | 80578篇 |
1990年 | 78396篇 |
1989年 | 75217篇 |
1988年 | 68334篇 |
1987年 | 66636篇 |
1986年 | 62998篇 |
1985年 | 59701篇 |
1984年 | 43794篇 |
1983年 | 37272篇 |
1982年 | 21037篇 |
1979年 | 39180篇 |
1978年 | 27025篇 |
1977年 | 23450篇 |
1976年 | 21308篇 |
1975年 | 23302篇 |
1974年 | 27759篇 |
1973年 | 26730篇 |
1972年 | 25055篇 |
1971年 | 23392篇 |
1970年 | 21590篇 |
1969年 | 20476篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Hassen Lena M. Albarrak Rana A. Albahlal Reem A. Alsaqabi Dimah K. Hassen Ikhlass M. Daghestani Maha H. Alqurtas Eman M. Alkhalaf Abdulaziz T. Bedaiwi Mohammed K. Omair Mohammed A. Almaghlouth Ibrahim A. 《Quality of life research》2022,31(11):3229-3239
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional... 相似文献
3.
Molnár B. Aroca S. Dobos A. Orbán K. Szabó J. Windisch P. Stähli A. Sculean A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with... 相似文献
4.
Kienbaum Peter Schaefer Maximilian S. Weibel Stephanie Schlesinger Tobias Meybohm Patrick Eberhart Leopold H. Kranke Peter 《Der Anaesthesist》2022,71(2):123-128
Die Anaesthesiologie - Auch wenn für Anästhesiologen über Jahrzehnte die Prophylaxe und Therapie postoperativer Schmerzen im Rahmen des postoperativen Patientenkomforts an vorderster... 相似文献
5.
6.
Georg Prokop Benedikt Wiestler Daniel Hieber Fynn Withake Karoline Mayer Jens Gempt Claire Delbridge Friederike Schmidt-Graf Nicole Pfarr Bruno Märkl Jürgen Schlegel Friederike Liesche-Starnecker 《International journal of cancer. Journal international du cancer》2023,153(9):1658-1670
Intratumor heterogeneity is a main cause of the dismal prognosis of glioblastoma (GBM). Yet, there remains a lack of a uniform assessment of the degree of heterogeneity. With a multiscale approach, we addressed the hypothesis that intratumor heterogeneity exists on different levels comprising traditional regional analyses, but also innovative methods including computer-assisted analysis of tumor morphology combined with epigenomic data. With this aim, 157 biopsies of 37 patients with therapy-naive IDH-wildtype GBM were analyzed regarding the intratumor variance of protein expression of glial marker GFAP, microglia marker Iba1 and proliferation marker Mib1. Hematoxylin and eosin stained slides were evaluated for tumor vascularization. For the estimation of pixel intensity and nuclear profiling, automated analysis was used. Additionally, DNA methylation profiling was conducted separately for the single biopsies. Scoring systems were established to integrate several parameters into one score for the four examined modalities of heterogeneity (regional, cellular, pixel-level and epigenomic). As a result, we could show that heterogeneity was detected in all four modalities. Furthermore, for the regional, cellular and epigenomic level, we confirmed the results of earlier studies stating that a higher degree of heterogeneity is associated with poorer overall survival. To integrate all modalities into one score, we designed a predictor of longer survival, which showed a highly significant separation regarding the OS. In conclusion, multiscale intratumor heterogeneity exists in glioblastoma and its degree has an impact on overall survival. In future studies, the implementation of a broadly feasible heterogeneity index should be considered. 相似文献
7.
8.
9.
10.
Karl Johnson Katherine W. Saylor Isabella Guynn Karen Hicklin Jonathan S. Berg Kristen Hassmiller Lich 《Genetics in medicine》2022,24(2):262-288
PurposeUnderstanding the value of genetic screening and testing for monogenic disorders requires high-quality, methodologically robust economic evaluations. This systematic review sought to assess the methodological quality among such studies and examined opportunities for improvement.MethodsWe searched PubMed, Cochrane, Embase, and Web of Science for economic evaluations of genetic screening/testing (2013-2019). Methodological rigor and adherence to best practices were systematically assessed using the British Medical Journal checklist.ResultsAcross the 47 identified studies, there were substantial variations in modeling approaches, reporting detail, and sophistication. Models ranged from simple decision trees to individual-level microsimulations that compared between 2 and >20 alternative interventions. Many studies failed to report sufficient detail to enable replication or did not justify modeling assumptions, especially for costing methods and utility values. Meta-analyses, systematic reviews, or calibration were rarely used to derive parameter estimates. Nearly all studies conducted some sensitivity analysis, and more sophisticated studies implemented probabilistic sensitivity/uncertainty analysis, threshold analysis, and value of information analysis.ConclusionWe describe a heterogeneous body of work and present recommendations and exemplar studies across the methodological domains of (1) perspective, scope, and parameter selection; (2) use of uncertainty/sensitivity analyses; and (3) reporting transparency for improvement in the economic evaluation of genetic screening/testing. 相似文献